Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis

  • Rivera-Esteban, Jesus M.D., Ph.D.
  • Valverde-Salazar, Víctor R.D.N.
  • Calleja, José L. M.D., Ph.D.

  • 1Hospital Universitario Puerta de Hierro Majadahonda, Madrid

Dr. Rivera-Esteban can be contacted at [email protected].

Drs. Rivera-Esteban and Calleja report having participated as investigators in the ESSENCE phase 3 trial. No other potential conflict of interest relevant to this letter was reported.

New England Journal of Medicine 393(8):p 827, August 21, 2025.
Copyright © 2025 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF